Singapore markets closed

Atara Biotherapeutics, Inc. (ATRA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.5110-0.0165 (-3.13%)
At close: 04:00PM EDT
0.5232 +0.01 (+2.39%)
After hours: 06:16PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 61.53M
Enterprise value 71.52M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.69
Price/book (mrq)N/A
Enterprise value/revenue 2.06
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.53
52-week change 3-73.25%
S&P500 52-week change 323.76%
52-week high 32.5350
52-week low 30.1990
50-day moving average 30.6367
200-day moving average 30.8574

Share statistics

Avg vol (3-month) 31.19M
Avg vol (10-day) 31M
Shares outstanding 5120.42M
Implied shares outstanding 6120.42M
Float 883.79M
% held by insiders 19.30%
% held by institutions 170.84%
Shares short (15 May 2024) 411.62M
Short ratio (15 May 2024) 49.33
Short % of float (15 May 2024) 49.79%
Short % of shares outstanding (15 May 2024) 49.65%
Shares short (prior month 15 Apr 2024) 411.45M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 0.00%
Operating margin (ttm)-96.85%

Management effectiveness

Return on assets (ttm)-59.06%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)34.7M
Revenue per share (ttm)0.30
Quarterly revenue growth (yoy)2,131.40%
Gross profit (ttm)N/A
EBITDA -215.79M
Net income avi to common (ttm)-233.11M
Diluted EPS (ttm)-2.1200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)46.24M
Total cash per share (mrq)0.38
Total debt (mrq)56.23M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.59
Book value per share (mrq)-0.82

Cash flow statement

Operating cash flow (ttm)-184.16M
Levered free cash flow (ttm)-25.14M